... upfront to the Indian drug maker for extending the vaccine rights to Canada. ... The Indian biotech company and Ocugen Inc have entered into a definitive ... to co-develop, supply, and commercialise Covaxin for the US market.
Read more: Ocugen pays USD 15 mn upfront to Bharat Biotech for Covaxin rights in Canada